UnknownNot Applicable

Safety and Efficacy of URS Stents in the Treatment of Ureteral Stricture

China500 participantsStarted 2020-01-01

Plain-language summary

A prospective observational study aimed to assess the efficacy and safety of Allium ureteral stent long-term indwelling in the treatment of ureteral stricture.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Benign diseases: UPJ, ischemic injury caused by surgical separation, endoscopic surgery injury, heat injury by laser lithotripsy, infection (chronic inflammation, tuberculosis), peri-ureteral fibrosis caused by endometriosis, ureteral anastomotic stenosis after renal transplantation, ureteral fistula, multiple polyps;
✓. Malignant diseases: ureteral anastomotic stricture after urinary diversion, stricture caused by compression of abdominal and/or pelvic tumors, stricture caused by urinary tract tumors, stricture caused by radiotherapy for colon or cervical cancer, ureteral fistula

Exclusion criteria

✕. Combine with hypertonic neurogenic bladder (except for patients with long-term indwelling catheter)
✕. Colon resection surgery patients -

What they're measuring

Patency rate

Timeframe: Up to 36 months

Indwelling time

Timeframe: Up to 36 months

Device related serious adverse events

Timeframe: Up to 36 months

Trial details

NCT IDNCT04129645

SponsorPeking University People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-01

Contact for this trial

Weihong Feng

86-10-68946338 fengwhr@139.com

View on ClinicalTrials.gov More Ureteral Stricture trials